Before you sell to, join or invest in Lomond Therapeutics Holdings, Inc.
MentionFox check on Lomond Therapeutics Holdings, Inc.: only 2 sources on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/lomond-therapeutics-holdings-inc-form-d-24000001
Check Lomond Therapeutics Holdings, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Lomond Therapeutics Holdings, Inc.?
Lomond Therapeutics Holdings, Inc. filed an amended Form D with the Securities and Exchange Commission on 2024-11-18.
Lomond Therapeutics Holdings, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on November 18, 2024. The filing reports $53.92M sold. Its industry group is Pharmaceuticals. It names Iain Dukes (Executive Officer, Director), Nikolay Savchuk (Executive Officer, Director), Carl Gordon (Director) (SEC Form D/A, November 18, 2024).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like Lomond Therapeutics Holdings, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-11-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Lomond Therapeutics Holdings, Inc.
Free to see. No signup.
Get an email when Lomond Therapeutics Holdings, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Lomond Therapeutics Holdings, Inc. raises, hires or launches. No email unless you switch it on.
Watch Lomond Therapeutics Holdings, Inc. →Get the full cited report on Lomond Therapeutics Holdings, Inc.
What the filing shows about Lomond Therapeutics Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Lomond Therapeutics Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Lomond Therapeutics Holdings, Inc.'s address as 8 The Green, Suite 8490, Dover, DE 19901.
Saved here on this device in the meantime, so nothing is lost either way.
Amended on 2025-02-11: the offering size changed from $43,900,000 to $63,915,492; the amount sold changed from $43,900,000 to $53,915,492; the number of investors changed from 27 to 28; sales commissions changed from $2,500,000 to $3,110,340. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Lomond Therapeutics Holdings, Inc. See pricing
Lomond Therapeutics Holdings, Inc. is a registered filer with the SEC (CIK 1900520) and has filed since 2024-11-18. 2 filings are on record, the latest on 2025-02-11.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Lomond Therapeutics Holdings, Inc.'s Form D of 2024-11-18 names Iain Dukes, Nikolay Savchuk, Carl Gordon and 1 more as its officers, directors or promoters.
Its new offerings report $43.90M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Iain Dukes is named as Executive Officer and Director on the Form D that Lomond Therapeutics Holdings, Inc. filed with the SEC on 18 November 2024, one of 4 people that filing names.
Nikolay Savchuk is named as Executive Officer and Director on the Form D that Lomond Therapeutics Holdings, Inc. filed with the SEC on 18 November 2024, one of 4 people that filing names.
Carl Gordon is named as Director on the Form D that Lomond Therapeutics Holdings, Inc. filed with the SEC on 18 November 2024, one of 4 people that filing names.
Eddie Rodriguez is named as Director on the Form D that Lomond Therapeutics Holdings, Inc. filed with the SEC on 18 November 2024, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2024-11-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Lomond Therapeutics Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Lomond Therapeutics Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lomond Therapeutics Holdings, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Lomond Therapeutics Holdings, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Lomond Therapeutics Holdings, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Lomond Therapeutics Holdings, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/lomond-therapeutics-holdings-inc-form-d-24000001